Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 10 | 4 | IMMUNOLOGY//TRANSPLANTATION//RHEUMATOLOGY | 1369268 |
| 255 | 3 | IMMUNOLOGY//CELLULAR IMMUNOLOGY//JOURNAL OF IMMUNOLOGY | 46035 |
| 1097 | 2 | INTERLEUKIN 2//OK 432//CANCER IMMUNOLOGY IMMUNOTHERAPY | 10078 |
| 18941 | 1 | SERV 151Z2//HIGH DIETARY FAT//STRITCH MED OTOLARYNGOL | 552 |
Terms with highest relevance score |
| rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|---|
| 1 | SERV 151Z2 | address | 146808 | 1% | 43% | 6 |
| 2 | HIGH DIETARY FAT | authKW | 114189 | 0% | 100% | 2 |
| 3 | STRITCH MED OTOLARYNGOL | address | 114189 | 0% | 100% | 2 |
| 4 | PP 2A | authKW | 101497 | 1% | 44% | 4 |
| 5 | BLADDER CANCER CYTOTOXICITY | authKW | 57095 | 0% | 100% | 1 |
| 6 | CANCER TREATMENT SYNERGIES | authKW | 57095 | 0% | 100% | 1 |
| 7 | CISTEM BIOTECHNOL GMBH | address | 57095 | 0% | 100% | 1 |
| 8 | CNRS ESA 6027GRP RECH THER EUT ANTICANC | address | 57095 | 0% | 100% | 1 |
| 9 | FLUORESCENCE BASED TELOMERIC REPEAT AMPLIFICATION PROTOCOL F TRAP | authKW | 57095 | 0% | 100% | 1 |
| 10 | FLUORESCENCE BASED TELOMERIC REPEAT AMPLIFICATION PROTOCOL TRAP | authKW | 57095 | 0% | 100% | 1 |
Web of Science journal categories |
| chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | Oncology | 3987 | 44% | 0% | 245 |
| 2 | Endocrinology & Metabolism | 247 | 9% | 0% | 51 |
| 3 | Medicine, Research & Experimental | 216 | 9% | 0% | 47 |
| 4 | Otorhinolaryngology | 213 | 5% | 0% | 25 |
| 5 | Immunology | 198 | 11% | 0% | 59 |
| 6 | Pharmacology & Pharmacy | 110 | 11% | 0% | 59 |
| 7 | Cell Biology | 90 | 9% | 0% | 47 |
| 8 | Surgery | 72 | 8% | 0% | 46 |
| 9 | Medicine, General & Internal | 66 | 7% | 0% | 37 |
| 10 | Urology & Nephrology | 47 | 3% | 0% | 19 |
Address terms |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | SERV 151Z2 | 146808 | 1% | 43% | 6 |
| 2 | STRITCH MED OTOLARYNGOL | 114189 | 0% | 100% | 2 |
| 3 | CISTEM BIOTECHNOL GMBH | 57095 | 0% | 100% | 1 |
| 4 | CNRS ESA 6027GRP RECH THER EUT ANTICANC | 57095 | 0% | 100% | 1 |
| 5 | GALILEE UP13 | 57095 | 0% | 100% | 1 |
| 6 | GYNECOL OBSTETICHIHARA HOSP | 57095 | 0% | 100% | 1 |
| 7 | INT PHARM HLTH SCI | 57095 | 0% | 100% | 1 |
| 8 | ISOTOP ASSAY | 57095 | 0% | 100% | 1 |
| 9 | MED BIOCHEM BOX 607 601 ELMWOOD AVE | 57095 | 0% | 100% | 1 |
| 10 | MED DENT JAMES BLACK FDN | 57095 | 0% | 100% | 1 |
Journals |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | INVASION & METASTASIS | 13016 | 2% | 2% | 10 |
| 2 | PROSTAGLANDINS LEUKOTRIENES AND MEDICINE | 7874 | 2% | 1% | 11 |
| 3 | PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS | 6516 | 3% | 1% | 19 |
| 4 | JOURNAL OF BIOLOGICAL RESPONSE MODIFIERS | 4209 | 1% | 1% | 6 |
| 5 | EKSPERIMENTALNAYA ONKOLOGIYA | 3724 | 2% | 1% | 9 |
| 6 | CANCER IMMUNOLOGY IMMUNOTHERAPY | 2501 | 3% | 0% | 14 |
| 7 | CLINICAL & EXPERIMENTAL METASTASIS | 2269 | 2% | 0% | 9 |
| 8 | PROSTAGLANDINS AND MEDICINE | 2258 | 1% | 1% | 3 |
| 9 | BRITISH JOURNAL OF CANCER | 1778 | 4% | 0% | 24 |
| 10 | PROSTAGLANDINS | 1473 | 1% | 0% | 6 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |